Page URL:
CONTENTS Issue #1127
Event Review: The Surrogacy Act
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Whole Genome Sequencing at Birth: Consenting Adults, Sequencing Babies
10 January 2022 - by Annabel Slater
The Progress Educational Trust's last event of 2021 continued the discussion about using whole genome sequencing in newborn babies... [Read More]
Embracing innovation for reproductive specimen management in IVF
10 January 2022 - by Rohit Gupta
All British people, with no exceptions, will soon be able to opt-in to store their sperm, eggs, and embryos for up to 55 years instead of ten thanks to a landmark campaign... [Read More]
Unvaccinated women denied fertility treatment in Scotland
10 January 2022 - by Ruth Retassie
Some patients in Scotland have had their treatment delayed because they are not fully vaccinated against COVID-19... [Read More]
Human embryo gene expression starts at one-cell stage
10 January 2022 - by Dr Maria Botcharova
A new study shows that embryos begin to show gene expression when they are just at the single-cell stage, right after fertilisation... [Read More]
Gene involved in sense of smell may play a role in breast cancer metastasis
10 January 2022 - by Anna Wernick
Not only do our olfactory receptors send smell signals to the brain, but they can also promote the spread of cancer there too... [Read More]
Fetal expression of imprinted genes regulates placental growth in late pregnancy
10 January 2022 - by Dr Emma Green
Scientists have determined the expression of two genes in the fetus, one from the mother and one from the father, is essential for regulation of blood vessel growth in the placenta... [Read More]
Knot-like DNA structures may drive cancer development
10 January 2022 - by Abbie Harper
DNA with knot-like structures and third rungs between the two strands may drive cancer development, with an important regulatory enzyme involved in the formation of these structures... [Read More]
Gene therapy developed to treat limb-girdle muscular dystrophy
10 January 2022 - by Dr Holly Barker
A new gene therapy approach has shown promise in a preclinical mouse model for treating limb-girdle muscular dystrophy 2B, a rare genetic disorder which causes severe muscle weakness... [Read More]
Liver fat directly increases risk of developing type 2 diabetes
10 January 2022 - by Jessica Peixinho
A recent study has found that a genetic predisposition to a fatty liver is key to the risk of developing type 2 diabetes... [Read More]
Event Review: The Surrogacy Act
10 January 2022 - by Anna Nelson
At the start of December I attended The Surrogacy Act – an event hosted virtually by Modern Art Oxford... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX